Back
Kaixin Holdings 10K Form
Sell
22
KXIN
Kaixin Holdings
Last Price:
$1.63
Seasonality Move:
-30.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2019-05-15 | 10Q | KXIN/Kaixin Holdings Quarterly |
2019-04-15 | 10K | KXIN/Kaixin Holdings Annual |
2019-03-25 | 10K | KXIN/Kaixin Holdings Annual |
2018-11-13 | 10Q | KXIN/Kaixin Holdings Quarterly |
2018-08-08 | 10Q | KXIN/Kaixin Holdings Quarterly |
2018-05-21 | 10Q | KXIN/Kaixin Holdings Quarterly |
Receive KXIN News And Ratings
See the #1 stock for the next 7 days that we like better than KXIN
KXIN Financial Statistics
Sales & Book Value
Annual Sales: | $31.5M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $46.51 |
Price / Book: | 0.04 |
Profitability
EPS (TTM): | -65.12720 |
---|---|
Net Income (TTM): | $-54.5M |
Gross Margin: | $342K |
Return on Equity: | 0% |
Return on Assets: | 0% |
Kaixin Holdings Earnings Forecast
Key Kaixin Holdings Financial Ratios
-
The Gross Profit Margin over the past 5 years for KXIN is 1.08%.
-
The Selling, General & Administrative Expenses for KXIN have been equal to 67.63% of Gross Profit Margin.
-
The Research & Development expenses have been 62.97% of Revenue.
-
The Interest Expense is -0.98% of Operating Income.
-
The Net Earning history of KXIN is -169.85% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Kaixin Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Specialty Retail |
Sector: | Consumer Discretionary |
Current Symbol: | KXIN |
Website: | ir.kaixin.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
KXIN Technical Analysis vs Fundamental Analysis
Sell
22
Kaixin Holdings (KXIN)
is a Sell
Is Kaixin Holdings a Buy or a Sell?
-
Kaixin Holdings stock is rated a SellThe current Kaixin Holdings [KXIN] share price is $1.64. The Score for KXIN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.